By Donald Zuhn — Last month, the Biotechnology Innovation Organization (BIO) and Pharmaceutical Research and Manufacturers of America (PhRMA) sent separate letters urging the Biden Administration to join the European Union, United Kingdom, Japan, Canada, Switzerland, Brazil, and Norway in opposing a proposal made by India and South Africa to have the World Trade Organization (WTO) waive the implementation, application and enforcement of certain provisions of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement with respect to the prevention, containment, or treatment of COVID-19. A group of fifteen industry and trade organizations (including BIO and PhRMA) followed with their…
